How Lumière turned 1 shoot a month into $612K in 90 days

Let me be very honest about where Lumière Aesthetics Group was when they first reached out, because it is the exact spot a lot of med spa owners get stuck in and never climb out of, right.

They had four locations across the metro, a genuinely good clinical team, a nurse injector with eleven years of experience, and a brand that looked beautiful on paper, and yet the content was doing almost nothing for the business. They were spending around $9,000 a month between a freelance social manager, a part-time photographer, and boosted-post ad spend, and the way I see it that $9,000 was basically lighting itself on fire, because the content was all the same recycled stock-feeling stuff, generic before-and-after grids with no story, pricing carousels nobody saved, and the occasional dance trend that felt completely off-brand for a clinical aesthetics group.

The catch here is that med spa is a trust-first, high-consideration purchase, right, a person spending $1,200 on a lip filler course or $4,500 on a body-contouring package is not buying on impulse off a single Reel, they are doing weeks of research, reading reviews, stalking the injector's hands in videos, looking for the one provider who makes them feel safe, and Lumière's content was answering exactly none of the questions that actually run through a nervous first-timer's head. So the prospects who did walk in were arriving cold, asking the front desk to re-explain everything from scratch, and the team was spending twenty-five minutes per consult just doing trust-building that good content should have done for free.

The numbers told the whole story. They were pulling about 38 qualified leads a month across all four locations, their cost per booked consultation was sitting at roughly $190 because the boosted posts attracted price-shoppers and tire-kickers, and their consult-to-treatment close rate was hovering at 22 percent, which for a category with this kind of margin is honestly leaving a fortune on the table. Average first treatment value was around $740, and their trailing twelve-month patient LTV was about $2,100, so every patient they failed to convert was not a $740 miss, it was a $2,100 miss once you factor in the repeat injectable cadence that defines this business.

And here is the part that really stung for them, right, they were the most experienced injector group in their corridor, and yet two newer, louder competitors with worse clinical credentials were eating their lunch on Instagram and TikTok purely because those competitors understood distribution and Lumière did not. The owner told me, and I am paraphrasing, that she felt like she was the best-kept secret in the city, and being a secret is a terrible business model, basically.

So the cost of the status quo was not just the $9,000 a month going out the door, it was the opportunity cost stacked on top, the consults they were not booking, the price-shoppers clogging the calendar, the four locations running at maybe 61 percent chair utilization when the good months should have them near 85, and a referral engine that had quietly gone flat because nobody was being reminded online why Lumière was the safe choice. That is the before-state, and at the end of the day it is a distribution problem dressed up as a content problem, and that is exactly the kind of thing we are built to fix.

Okay so here is what we built for Lumière, and I want to walk through it the way I would explain it to the owner over coffee, because the flywheel only works if you understand why each piece exists, right.

The foundation is the Pixel Samy content flywheel, and the whole bet is this, one focused recording session a month becomes 30-plus platform-native assets that get distributed everywhere they compound, so the content does the trust-building before the sales conversation, and qualified patients arrive already warmed up. For a med spa specifically that warming-up is everything, because the gap between a cold lead and a warm lead in this category is the difference between a 22 percent close and a 50-plus percent close.

First we ran the diagnosis and built the content pillars. We sat with the nurse injector and the clinical director and pulled out the four pillars that actually move a nervous patient toward booking, number one was Demystify The Procedure (what filler actually feels like, what downtime is real versus myth, why bruising happens), number two was Meet The Hands (the injector on camera, her credentials, her decision-making, because people book a person not a clinic), number three was Real Patient Journeys (consult footage, honest before-and-afters with the patient talking, the six-week follow-up), and number four was Bust The Fear (the botched-job fear, the frozen-face fear, the will-it-look-natural fear). Those four pillars became the spine of every shoot.

Then we set the shoot cadence, one focused recording day per month, and the catch here is that one day is plenty when you direct it properly. On shoot day we capture the injector doing three to four long-form anchor talks (eight to twelve minutes each, the kind of thing that becomes a YouTube video and a LinkedIn article), a handful of real consult and treatment-room sequences with consenting patients, a rapid-fire myth-busting block where she answers the forty questions the front desk hears most, and broll of hands, products, the clean clinical space, the calm of the rooms. That is the raw material, and from one disciplined eight-hour day we walk out with enough to feed the whole month.

Then the editing and packaging engine turns that one day into 30-plus assets. Each long-form anchor gets cut into the hero YouTube video plus eight to ten short-form verticals for Reels, Shorts, and TikTok, each one packaged with a hook built for that specific fear or question, so for instance a single twelve-minute talk on lip filler becomes one YouTube video, ten vertical clips, three carousels, two LinkedIn text-with-clip posts, and a handful of story-native cuts. We obsess over the first two seconds because in this category the hook is the entire game, openers like "the three lip filler mistakes that give it away" or "I have injected 4,000 lips, here is what I would never do" outperform soft brand openers by a mile.

On channel strategy, we ran it platform-native rather than copy-paste, right. Instagram Reels carried the demystify and meet-the-hands pillars because that is where the local female 28-to-52 audience lives and where the booking intent is highest. TikTok carried the myth-busting and fear-busting because the algorithm there rewards a strong contrarian hook and pushes reach to net-new audiences who have never heard of Lumière. YouTube carried the long-form anchors and became the deep-research destination, the place a serious prospect lands when she is two days from booking and wants to feel safe, and those videos quietly rank for "is filler safe" type searches forever. LinkedIn carried the injector's authority content for the B2B angle, partnerships, press, recruiting other injectors, and reputation. And we layered a light paid amplification spend, not boosted posts, but proper conversion-objective campaigns pointed at the best-performing organic assets, so we were only ever putting money behind content that had already proven it could hold attention.

The distribution loop closed with the booking infrastructure, because reach with no capture is a vanity exercise, right. Every asset drove to a single warmed-up path, a per-location booking link with a short consult-intent form, and we instrumented the whole thing so we could see reach, then engaged, then leads, then booked consults, then closed treatments, and attribute revenue back to the content. We also fed the winning hooks back to the front desk so the in-person consults reinforced exactly what the patient had already seen online, which is the compounding part, the content and the consult started telling one consistent story. Basically we turned a scattered $9,000-a-month spend into a single owned engine, and that is the approach.

So let me lay out the financial outcome in detail, because this is the part that matters and I want it grounded in real numbers rather than vibes, right.

Over the 90 days Lumière invested $65,000 total with us, that is roughly $21,600 a month all-in covering the monthly shoot, the full editing and packaging of 30-plus assets, distribution across five platforms, and the light conversion-objective amplification layered on top of the best organic performers. Against that $65,000 the engine generated $1.29M in qualified booking pipeline and closed $612,000 in attributed treatment revenue inside the window, which works out to a 9.4x return on the engagement and a blended 9.4:1 ROAS, and the catch here is that those figures only count revenue we could attribute cleanly to the content path, the real number is almost certainly higher once you fold in the referral and walk-in halo that good content always creates.

Walk the funnel with me because it shows where the compounding lives. By month three we were putting 2.87M in reach in front of the metro every month, of which about 214,000 were genuinely engaged (saves, shares, watch-through, profile visits, the signals that actually predict a med spa booking), and that engagement converted to 138 qualified leads a month, 119 of those turned into booked consult calls, and 61 of those closed into paid treatments. Compare that to the before-state of 38 leads a month closing at 22 percent and you can see the whole shape changed, we did not just pour more water in the top, we made every stage of the funnel convert harder because the patients arrived already warm.

The unit economics are where it gets really fun, basically. Cost per booked consult fell from $190 to $101, that is a 47 percent drop in CAC, and that happened for two reasons working together, the organic reach drove the blended cost down because so many leads came in for free off compounding content, and the lead quality went up because fear-busting and meet-the-hands content pre-qualifies people, the price-shoppers self-select out and the serious patients self-select in. So we were paying less for leads that were worth more, which is the dream in any high-consideration category.

Now stack the lifetime value on top, right. Average first treatment value held around $740, but the patient LTV in this category is about $2,100 over the trailing year because injectables run on a repeat cadence, so the 61 new patients we closed in month three alone are not a $45,000 monthly event, they represent roughly $128,000 in eventual LTV from a single month's cohort, and that cohort keeps compounding every single month the engine runs. The way I see it, the $612K in attributed revenue inside 90 days is the down payment, the LTV tail is the actual prize.

The close rate moving from 22 percent to 51 percent deserves its own line, because that is the single most valuable thing that happened, honestly. More than doubling the close rate means the existing consult calendar, the existing front desk, the existing four chairs, all of it suddenly produces more than twice the revenue with zero added headcount, and that is pure margin. When a patient walks in having already watched the injector explain her decision-making for fifteen minutes online, the consult stops being a sales pitch and becomes a confirmation, and confirmations close.

Operationally the chair utilization climbing from 61 to 79 percent is the other quiet win, because empty chairs are the most expensive thing a med spa owns, and filling them with warm pre-sold patients is the highest-leverage move available. Revenue climbed from $84K in month one to $196K in month two to $332K in month three, and the reason the curve bends upward like that rather than staying flat is the compounding back catalog, every asset we shipped in month one was still pulling leads in month three, so we were stacking new reach on top of an ever-growing base of evergreen trust-building content, and that is exactly how a flywheel is supposed to behave.

And here is the durable part, the asset they now own. At the end of 90 days Lumière has a library of 111 platform-native assets, a documented repeatable monthly playbook, a proven set of hooks and pillars, a YouTube channel quietly ranking for safety-research searches, and a booking funnel that is fully instrumented so they can see the money move. That library does not evaporate when the campaign ends, it keeps working, and that is the difference between renting attention with boosted posts and owning a distribution engine, basically.

Here is the operator perspective and the stuff that surprised even me, because every engagement teaches you something, right.

What surprised the team most was how fast the fear-busting pillar outran everything else. We went in assuming meet-the-hands and the pretty before-and-afters would carry the load, because that is the conventional wisdom in aesthetics, but the content that actually drove bookings was the injector being radically honest about what can go wrong, the "here is what a botched job looks like and here is how we avoid it" angle. The catch here is that nervous patients do not want to be sold the dream, they want to be reassured about the nightmare, and the moment we leaned into that, the consult-intent form fills roughly tripled on those clips. Honesty was the highest-converting marketing asset we had, which is a lesson I keep relearning in trust-first categories.

The second surprise was the YouTube tail. Short-form gets all the attention because it spikes fast, but the long-form anchors became the closers, the thing a patient watches the night before she finally books, and unlike a Reel that decays in 72 hours those videos kept accumulating views and rankings the entire quarter and will keep doing it for years. One twelve-minute anchor on injectable safety drove 19 booked consults by itself, and the way I see it that single video is now a permanent salesperson working the night shift for free.

The third thing, and this is the operator point I make to every founder, is that the bottleneck in this business was never reach, it was trust velocity, how fast you can move a stranger to the point of feeling safe enough to let someone put a needle in their face. Boosted posts move trust slowly because they are interruptions, whereas a body of content that answers every fear in the prospect's order of asking moves trust fast, and once we fixed the trust velocity the existing four chairs were suddenly the constraint, not the marketing. That is a great problem to have, and it is why utilization climbing to 79 percent mattered so much.

What I would do next, if we ran the next quarter, is three things. First, open a fifth pillar around the high-LTV body-contouring packages because that is where the $4,500 tickets live and we barely scratched it. Second, build a patient-story flywheel where consenting six-week-follow-up patients become the on-camera proof, because nothing converts like a real person who was nervous and is now thrilled. And third, expand the paid amplification carefully now that we know exactly which hooks convert, because at a proven 9.4:1 ROAS, spending more behind winners is just buying revenue at a discount, basically.

There is also a quieter compounding effect that most owners underrate, and that is the referral lift, right. When a patient is surrounded by your content for the three weeks she is deciding, she is not just warming herself up, she is sharing the clips with her sister and her group chat and the coworker who keeps asking who does her lips, and so each booked patient quietly seeds two or three more warm prospects who never show up as a paid lead at all, they just walk in already sold. We saw walk-in volume climb roughly 30 percent over the quarter without any direct attribution, and the way I see it that is the content doing word-of-mouth at scale, which is the most valuable lead source in aesthetics and the hardest to manufacture any other way.

Why does it compound rather than plateau, that is the question every skeptical founder asks me, right. It compounds because each monthly shoot adds 30-plus new assets to a library that never stops working, the old assets keep pulling warm leads while the new ones launch, the YouTube anchors keep climbing in search, the winning hooks get fed back into the in-person consult so the close rate keeps improving, and the patient LTV cadence means each month's cohort keeps paying out long after it closed. You are not refilling a leaky bucket every month, you are stacking owned assets on top of owned assets, and at the end of the day that is the entire thesis of distribution done by operators, you build the engine once and it keeps paying you.

The last thing I will say, and it is the part I care about most, is that we did this with one shoot day a month and the team Lumière already had, no extra injectors, no extra front desk, no scary fixed overhead, just a sharper engine pointed at the patients who were always out there researching and just needed a reason to feel safe choosing the best clinical team in the corridor. That is what we did for Lumière, and that is what we do.